EDIT Editas Medicine Inc.

$37.815 -0.49%

838,176 Shares Traded
1,591,152 Average Volume (last 30 days)

as of March 23, 2018 EST IEX Real-Time Price

Short Pain Metrics

Approximate Amount of Money Shorts Have Made on the Day: $1.12 million
If Intiated on the First, Shorts Have Realized a Year to Date Return of:-10.72%
If Intiated One Month Ago, Shorts Have Realized a Return of:-14.18%
If Initiated Five Days ago, Shorts Have Realized a Return of:0.05%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bullish
50 Day Moving Average Indicator Bullish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 13.46%
Short Interest6.04 million
Float44.91 million
Short Ratio4.03
Market Cap$1.78 billion
Market Maker ActivityDaily Short Volume


Biotechs Approaching New Waters (SeekingAlpha)
Editas Medicine (EDIT) Presents At 38th Annual Cowen And Company Healthcare Conference - Slideshow (SeekingAlpha)
Specialty Research: Stellar Gene Therapy And Gene Editing Innovators (SeekingAlpha)
Editas Medicine's (EDIT) CEO Katrine Bosley on Q4 2017 Results - Earnings Call Transcript (SeekingAlpha)
After-hours buzz: URBN, ADSK, HRB, CAT, BA & more (CNBC)
After Hours Gainers / Losers (3/6/2018) (SeekingAlpha)
Editas Medicine misses by $0.06, misses on revenue (SeekingAlpha)
Notable earnings after Tuesday's close (SeekingAlpha)
Gilead's Hunt And The Crispr Crapshoot (Podcast) (SeekingAlpha)
Sangamo Therapeutics: Great Start To 2018 - $3 Billion KITE Announcement (SeekingAlpha)

Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 56.5%

Earnings Stats

PE Ratio -12.72
Dividend Yield 0%
Peer EarningsEarnings Calendar


200 Day Moving Average $25.36
50 Day Moving Average $36.08
52 Week High $45.02
52 Week Low $13.12

Data provided for free by IEX. Questions? Read the FAQ